Arrowstreet Capital’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $184M | Buy |
|
|||||
|
2021
Q1 | $12.6M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $1.18M | Sell |
|
|||||
|
2020
Q1 | $28M | Buy |
|
|||||
|
2019
Q4 | $12.4M | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $1.74M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $19.8M | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $87.1M | Buy |
|
|||||
|
2018
Q1 | $52.8M | Buy |
|
|||||
|
2017
Q4 | $37.2M | Buy |
|
|||||
|
2017
Q3 | $3.93M | Sell |
|
|||||
|
2017
Q2 | $5.92M | Buy |
|
|||||
|
2017
Q1 | $3.6M | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $2.14M | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $34.4M | Buy |
|
|||||
|
2014
Q2 | $11.8M | Buy |
|
|||||
|
2014
Q1 | $8.65M | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $32.5M | Buy |
|